Fu-Chi Yang

Economic evaluation of atogepant compared to placebo for the preventive treatment of episodic migraine in Taiwan

Abstract Objectives This study evaluated the cost-effectiveness of atogepant, an oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the preventive treatment of episodic migraine in adults from the perspective of Taiwan’s National Health Insurance (NHI) system. M...